Cargando...
Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure
BACKGROUND: For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfortunately, survival is still poor due to distant metastases, which remains the leading cause of...
Gardado en:
| Publicado en: | World J Gastrointest Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Baishideng Publishing Group Inc
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7896420/ https://ncbi.nlm.nih.gov/pubmed/33643528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v13.i2.119 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|